Elevance Health Q4 FY24: where the revenue came from and where it went
The whole income statement of Elevance Health for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Oct 1 – Dec 31, 2024
- Reported
- Feb 20, 2025
Revenue$45.4B
+7% year over year
Gross profit$39.4B
87% margin
Operating profit$0.7B
1% margin
Net profit$0.4B
1% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 45.4 | 100% | +7% |
| CarelonRx | 36.0 | 79% | |
| Health Benefits | 7.6 | 17% | |
| Carelon Services | 0.8 | 2% | |
| Other revenue | 0.8 | 2% | |
| Corporate & Other | 0.3 | 0% | |
| Other and unallocated | −0.1 | 0% | |
| Cost of revenue | −6.0 | 13% | |
| Gross profit | 39.4 | 87% margin | −2pp |
| SG&A | −4.8 | 10% | −1pp |
| Other | −34.0 | 75% | +0pp |
| Operating profit | 0.7 | 1% margin | −2pp |
| Interest & other costs | −0.1 | ||
| Tax | −0.2 | ||
| Net profit | 0.4 | 1% margin | −1pp |
326 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest